These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 15452231)
21. A Panel of Kaposi's Sarcoma-Associated Herpesvirus Mutants in the Polycistronic Kaposin Locus for Precise Analysis of Individual Protein Products. Kleer M; MacNeil G; Adam N; Pringle ES; Corcoran JA J Virol; 2022 Mar; 96(5):e0156021. PubMed ID: 34936820 [TBL] [Abstract][Full Text] [Related]
22. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388 [TBL] [Abstract][Full Text] [Related]
24. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection. Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721 [TBL] [Abstract][Full Text] [Related]
25. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase. Cheng F; He M; Jung JU; Lu C; Gao SJ J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746 [TBL] [Abstract][Full Text] [Related]
26. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452 [TBL] [Abstract][Full Text] [Related]
27. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling. Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900 [TBL] [Abstract][Full Text] [Related]
28. Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36. Avey D; Tepper S; Pifer B; Bahga A; Williams H; Gillen J; Li W; Ogden S; Zhu F J Virol; 2016 Jul; 90(13):5953-5964. PubMed ID: 27099309 [TBL] [Abstract][Full Text] [Related]
29. iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release. Dollery SJ; Maldonado TD; Brenner EA; Berger EA Front Cell Infect Microbiol; 2021; 11():654396. PubMed ID: 33937098 [TBL] [Abstract][Full Text] [Related]
30. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025 [TBL] [Abstract][Full Text] [Related]
31. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. Punjabi AS; Carroll PA; Chen L; Lagunoff M J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100 [TBL] [Abstract][Full Text] [Related]
32. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency. Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794 [TBL] [Abstract][Full Text] [Related]
33. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus. King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061 [TBL] [Abstract][Full Text] [Related]
34. Identification of the Essential Role of Viral Bcl-2 for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. Liang Q; Chang B; Lee P; Brulois KF; Ge J; Shi M; Rodgers MA; Feng P; Oh BH; Liang C; Jung JU J Virol; 2015 May; 89(10):5308-17. PubMed ID: 25740994 [TBL] [Abstract][Full Text] [Related]
36. The Viral Bcl-2 Homologs of Kaposi's Sarcoma-Associated Herpesvirus and Rhesus Rhadinovirus Share an Essential Role for Viral Replication. Gallo A; Lampe M; Günther T; Brune W J Virol; 2017 Mar; 91(6):. PubMed ID: 28053098 [TBL] [Abstract][Full Text] [Related]
37. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation. Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356 [TBL] [Abstract][Full Text] [Related]
38. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma. Jiang Y; Xu D; Zhao Y; Zhang L PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508 [TBL] [Abstract][Full Text] [Related]
39. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation. Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497 [TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Cathomas G Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]